BKYI

BIO-key International Inc. Common Stock (BKYI)

Stock · NASDAQ · Technology

$2.68as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

BKYI Partners With Al Majlis Group for Middle East Expansion. BIO-key International announced a partnership with Al Majlis Group to expand its identity security services in the UAE and Saudi Arabia. This move signals a strategic push into the Middle East market. The stock is currently trading near its 52-week low, with an RSI of 41.9 indicating neutral momentum.

Active signals

Resistance level
$4.11
Industry
Computer Software: Prepackaged Software

What BKYI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown23-2.6%43%
Volume Spike23-14.0%22%
Bollinger Band Breakout15-15.0%13%
200-Day Moving Average TouchActive now3-9.1%33%
Any 20-session window (baseline)-6.2%32%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BKYI

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastr…

Sector
Technology
Industry
Computer Software: Prepackaged Software
Employees
41

Fundamentals

1-day range
$2.51$3.11
Market cap
$4.33M
P/E (trailing)
—
P/E (forward)
11.95
EPS (trailing)
$-3.62
Dividend yield
—
Beta
0.52
Avg. volume
4.15M
Dividend pay date
November 20, 2020
52-week range
$1.55$19.7

How BIO-key International Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$5.94MSG&A$6.28M (106%)R&D$2.61M (44%)Cost of Revenue$1.37M (23%)Tax$16.5K (0%)BKYI

Source: 10-K filed Jun 12, 2026 · via SEC EDGAR / Finnhub

Gross Profit$4.56M(77%)
Operating Income-$6.83M(-115%)

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$20
+646.3%
Median
$20
+646.3%
Low
$20
+646.3%

BIO-key International Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • BKYI
    BIO-key International Inc. Common Stock
    $2.63
    ▼ 10.85%
    Market cap $4.33MP/E —
    $1.55$19.7
  • FRSX
    Foresight Autonomous Holdings Ltd. American Depositary Shares
    $0.83
    ▼ 4.27%
    Market cap $3.70MP/E —
    $2.8$30
  • EXYNW
    Exyn Technologies Inc. Warrant
    $0.275
    ▼ 8.33%
    Market cap $5.01MP/E —
    $0.05041$1.45
  • IVDA
    Iveda Solutions Inc. Common Stock
    $0.23
    ▲ 0.00%
    Market cap $3.32MP/E —
    $0.211$1.52
  • DFSC
    DEFSEC Technologies Inc. Common Stock
    $0.714
    ▼ 2.19%
    Market cap $3.28MP/E —
    $1.06$8.37
  • AIXI
    XIAO-I Corporation American Depositary Shares
    $2.92
    ▲ 3.91%
    Market cap $2.90MP/E —
    $1.18$379.4
  • ORKT
    Orangekloud Technology Inc. Class A Ordinary Shares
    $1.05
    ▲ 6.06%
    Market cap $5.84MP/E —
    $0.617$2.49

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.